Does CISATRACURIUM Cause Hyperthermia malignant? 60 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 60 reports of Hyperthermia malignant have been filed in association with CISATRACURIUM (cisatracurium besylate). This represents 3.5% of all adverse event reports for CISATRACURIUM.
60
Reports of Hyperthermia malignant with CISATRACURIUM
3.5%
of all CISATRACURIUM reports
14
Deaths
29
Hospitalizations
How Dangerous Is Hyperthermia malignant From CISATRACURIUM?
Of the 60 reports, 14 (23.3%) resulted in death, 29 (48.3%) required hospitalization, and 23 (38.3%) were considered life-threatening.
Is Hyperthermia malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CISATRACURIUM. However, 60 reports have been filed with the FAERS database.
What Other Side Effects Does CISATRACURIUM Cause?
Anaphylactic shock (221)
Hypotension (113)
Off label use (109)
Anaphylactic reaction (107)
Anaesthetic complication neurological (89)
Drug ineffective (71)
Cardiac arrest (67)
Drug reaction with eosinophilia and systemic symptoms (67)
Toxic epidermal necrolysis (63)
Erythema (47)
What Other Drugs Cause Hyperthermia malignant?
SUCCINYLCHOLINE (276)
SEVOFLURANE (207)
PROPOFOL (205)
FORANE (170)
ROCURONIUM (114)
FENTANYL (107)
SEVOFLURANE, USP (93)
ISOFLURANE (87)
MIDAZOLAM (62)
SUFENTANIL (56)
Which CISATRACURIUM Alternatives Have Lower Hyperthermia malignant Risk?
CISATRACURIUM vs CISPLATIN
CISATRACURIUM vs CISPLATIN\CYTARABINE\DEXAMETHASONE
CISATRACURIUM vs CITALOPRAM
CISATRACURIUM vs CITALOPRAM HYDROBROMIDE
CISATRACURIUM vs CITALOPRAM\CITALOPRAM HYDROBROMIDE